Male hypogonadism: a review

Marcelli M, Mediwala SN

Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2020

Abstract

This article contains a systematic review of the main developments that have occurred in the area of male hypogonadism between the publication of the Endocrine Society Guidelines of 2010 and 2018 and after 2018.

How strong is the evidence?

Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents Bioorganic & medicinal chemistry letters, 2020
On model selections for repeated measurement data in clinical studies Statistics in medicine, 2015
Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells Endocrinology, 2014
Region-specific microRNA signatures in the human epididymis Asian journal of andrology, 2018
Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety Bioorganic & medicinal chemistry, 2019
In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor Journal of hazardous materials, 2022

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free